Marker May Explain Poor Outcomes in Black Breast Cancer Patients Marker May Explain Poor Outcomes in Black Breast Cancer Patients
A study of tumor microenvironments suggests that breast tumors in Black women may have a stronger prometastatic response to neoadjuvant chemotherapy than tumors in White women.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Women